| Document |
Document Title |
|
WO/2023/237038A1 |
Akkermansia muciniphila strains, which respectively have the preservation numbers CGMCC No. 22793 and CGMCC No. 22794, probiotic combination products comprising said strains, a health food or a pharmaceutical composition, a method for cu...
|
|
WO/2023/236634A1 |
Provided are an EP6 promoter, a related biomaterial, and use thereof. The sequence of the EP6 promoter is set forth in SEQ ID No. 3 in the sequence listing. The EP6 promoter is used as an exogenous strong promoter to be integrated into b...
|
|
WO/2023/238843A1 |
The present invention relates to a microorganism which has an enhanced activity of a protein consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by deletion of 20-37 amino acid residues o...
|
|
WO/2023/240293A2 |
Provided are modified gRAMP proteins that have one or more mutations relative to an unmodified Candidatus scalindua gRAMP protein. The modifications may be at positions 806, 547, 367, 371, 328, or a combination thereof. The modifications...
|
|
WO/2023/236496A1 |
A method for counting the number of intrauterinely developed embryos of Caenorhabditis elegans. By using Caenorhabditis elegans as a model organism, a whole set of experimental process is designed to detect and count the number of embryo...
|
|
WO/2023/239868A1 |
Provided are methods to produce an edible filamentous fungal biomass using an aqueous media which has a carbon source and a nitrogen source into which is inoculated filamentous fungal culture followed by culturing in a submerged fungal c...
|
|
WO/2023/237871A1 |
The invention relates to enhanced fungal mats having enhanced mechanical properties compared to naturally-occurring fungal mats produced by a fungus or fungi of the same species. The invention also relates to materials comprising said en...
|
|
WO/2023/237067A1 |
The use of Akkermansia muciniphila or a composition containing Akkermansia muciniphila in preparation of a pharmaceutical composition or a health care product composition for improving metabolic syndrome. The Akkermansia muciniphila is A...
|
|
WO/2023/238635A1 |
In the present invention, lithium can be easily and efficiently recovered from a lithium-containing starting liquid, using a lithium recovery agent containing an electricity-generating bacterium and a lithium intercalation material.
|
|
WO/2023/239939A1 |
The present disclosure provides compositions and methods for producing a cell culture product in a cell culture composition, particularly for cell culture product s that impair the growth and/or function of the host cells in which they a...
|
|
WO/2023/239061A1 |
The present invention relates to a method for recovering metals from a waste battery by using a magnetic field-applied biological leaching process. According to the method of the present invention, by applying a magnetic field to the bio...
|
|
WO/2023/240110A1 |
The subject invention provides safe, environmentally-friendly compositions and efficient methods for flocculation. More specifically, the subject invention provides compositions derived from microorganisms for flocculation, which can be ...
|
|
WO/2023/239024A1 |
The present invention relates to a microorganism belonging to the Iamiaceae family, which has phylogenetically and chemotaxonomically different characteristics compared to strains from the same or different genus. In addition, the strain...
|
|
WO/2023/239814A1 |
A genetically engineered Escherichia coli Nissle 1917 bacterium is provided. The genetically engineered bacterium comprises an overexpressed number of FyuA receptors. In one embodiment, the genetically engineered bacterium comprises the ...
|
|
WO/2023/240237A2 |
Compositions and methods for reducing or eliminating biofilm formation are disclosed. The compositions include an O-glycan substituted silk fibroin with a predetermined degree and distribution of O-glycan substitution. The O-glycan subst...
|
|
WO/2023/233138A1 |
The present invention relates to metagenomics methods. The invention also relates to their use in the detection and/or diagnosis of a wide range of infectious diseases, for example, caused by a pathogenic virus, bacterium, fungus or prot...
|
|
WO/2023/230686A1 |
Opportunistic pathogenic nematoids and fungi in the soil are controlled using graphite, talcum and fungus colonies, with application in agriculture, more specifically for treating seeds before sowing, wherein a fungus is added, controlli...
|
|
WO/2023/231853A1 |
Bacillus subtilis FNFH_BS06 and the use thereof, which belongs to the technical field of microorganisms. On the one hand, provided is Bacillus subtilis FNFH_BS06, with the deposit number of CGMCC No.24836, and on the other hand, provided...
|
|
WO/2023/230736A1 |
The present invention relates to a composition for the treatment and prevention of American foulbrood (AFB) to protect honey bee apiaries, a method for obtaining said composition and the use thereof for the prevention and treatment of mi...
|
|
WO/2023/233403A1 |
There is provided a synthetic composition including: (a) bacterial consortium including: (i) at least three bacterial species belonging to the genus Bacillus; and (ii) at least three bacterial species belonging to the genus Lacticaseibac...
|
|
WO/2023/232863A1 |
The invention relates to a process for reusing heat in a protein culture, the process comprising the steps of aerobically fermenting a material with an thermophilic organism to provide a thermophilic fermented culture; and performing a d...
|
|
WO/2023/230654A2 |
The disclosure relates generally to a bacterial culture or clarified bacterial culture supernatant comprising propionic acid for use as a component of an emulsion, wherein the emulsion is adapted to increase the spreadability of a pestic...
|
|
WO/2023/234419A1 |
Provided is, for example, a DNA methyltransferase that can recognize and methylate a short context other than a CG dinucleotide sequence in which endogenous methylation occurs, the short context being comparable to the CG dinucleotide se...
|
|
WO/2023/234767A1 |
There are closed systems of growing microalgae but as they are not able to produce algal biomass economically they are very few and far between and are only used to grow microalgae for very expensive produce. These closed systems also re...
|
|
WO/2023/234587A1 |
The present invention relates to a novel strain, a lysate thereof, a culture medium, an extract of the culture medium, and anti-inflammatory uses thereof. A strain and a culture medium derived therefrom, according to one aspect, can be e...
|
|
WO/2023/231489A1 |
Disclosed in the present invention is a preparation method for a biosynthetic human body structural material. The present invention provides a recombinant humanized collagen type IV, the amino acid sequence thereof comprising n repetitiv...
|
|
WO/2023/234330A1 |
The present invention addresses the problem of providing an EGFR CAR-T cell which is expected to be effective against a tumor in which an EGFR is expressed. The present invention provides: a polynucleotide encoding a chimeric antigen rec...
|
|
WO/2023/234620A1 |
The present invention relates to a novel strain having resistance to methylglyoxal and activity to reduce advanced glycation end products (AGEs), and a composition including the strain. The strain and the composition not only have resist...
|
|
WO/2023/234416A1 |
The present invention relates to a technology for facile chemical modification of only one heavy chain in an antibody structural unit (immunoglobulin unit comprising two heavy chains and optionally two light chains). More specifically, t...
|
|
WO/2023/234739A1 |
The present application relates to a Corynebacterium sp. recombinant microorganism with L-ornithine production capability, which includes the LysE/ArgO family amino acid transporter protein derived from the Shewanella strain or a polynuc...
|
|
WO/2023/234409A1 |
The present invention provides: a composition which is for increasing the efficiency of genome editing with a single-strand-form editing polynucleotide that is capable of modifying a target site in a double-stranded genome DNA, the compo...
|
|
WO/2023/231149A1 |
The present invention provides a recombinant Orthohepevirus genotype C1 ORF2 protein and a preparation method therefor and use thereof, and belongs to the technical field of hepatitis E virus. A recombinant rat HEV-C1 ORF2 protein provid...
|
|
WO/2023/234307A1 |
The purpose of the present invention is to enhance ergothioneine productivity in ergothioneine production through culturing of an ergothioneine-producing filamentous fungus. In the present invention, a genetic mutation that enhances er...
|
|
WO/2023/230745A1 |
The present invention provides engineered bacteria capable of producing bacterial cellulose for producing a targeted therapeutic active ingredient and a preparation method for the engineered bacteria. Host bacteria of the engineered bact...
|
|
WO/2023/231854A1 |
Bacillus subtilis FNFH_BS08 is provided, and a use of the Bacillus subtilis FNFH_BS08 is also provided; the Bacillus subtilis FNFH_BS08 can efficiently degrade the main antigenic proteins and non-starch polysaccharides of bean pulp by me...
|
|
WO/2023/234558A1 |
The present invention relates to a fermented banana beverage and a manufacturing method therefor. The manufacturing method is characterized by comprising the steps of: (S10) washing bananas and removing the peels thereof; (S20) crushing ...
|
|
WO/2023/232871A1 |
The present invention relates to the field of frozen or dry compositions for prokaryotes, in particular fermentative bacteria such as lactic acid bacteria, a method for preparing frozen or dry prokaryotic compositions with improved stabi...
|
|
WO/2023/233996A1 |
The present disclosure provides a modified promoter capable of flexibly regulating the expression level of a gene encoding a protein. The modified promoter according to the present disclosure is a promoter modified by, with respect to a ...
|
|
WO/2023/231547A1 |
Provided are an NCgl2747 gene mutant and the use thereof in the preparation of L-lysine. The NCgl2747 gene mutant is a DNA molecule shown in SEQ ID No.3, which encodes the NCgl2747 mutant protein shown in SEQ ID No.4. Mutating the NCgl27...
|
|
WO/2023/235702A1 |
A bioremediation method comprising: providing an alkalinizing acidophilic fungus, contacting an acidic liquid having a pH of 5 or lower with the fungus, and maintaining the acidic liquid under conditions sufficient to permit the fungus t...
|
|
WO/2023/232583A1 |
The present invention relates to a microorganism transformed to be capable of producing guanidinoacetic acid (GAA) and comprising at least one gene coding for a protein having the function of a NADH-dependent dehydrogenase and to a metho...
|
|
WO/2023/227681A1 |
The present invention relates to a method of preparing native protein of a microorganism comprising lysing the microorganism, separating lipids from the supernatant, filtering the supernatant and optionally separating nucleic acids, ster...
|
|
WO/2023/228814A1 |
The present invention provides a microarray chip that makes it possible to reliably separate a large number of single cells and highly efficiently culture monoclonal colonies. Provided is a microarray chip 1 having formed therein a plu...
|
|
WO/2023/226430A1 |
A method for preparing a shrimp paste on the basis of fast fermentation strengthened with combined strains, and the shrimp paste prepared by same. The method comprises the following steps: (1) crushing Acetes chinensis to obtain a shrimp...
|
|
WO/2023/229493A1 |
A microbiological preparation intended for detoxifying soil and remediating contaminated natural environments (earth, soil, bodies of water) of persistent organic contaminants of the chlorinated aromatic and phenolic kind. Proposed is a ...
|
|
WO/2023/229446A1 |
The present invention relates to a method for constructing Gram-negative bacterial outer membrane-derived nanovesicles and a use thereof. Also, the present invention provides a method for treating or diagnosing cancer using Gram-negative...
|
|
WO/2023/229309A1 |
The present invention relates to a Lactobacillus paracasei UOS1 strain having antibacterial activity and provides an antibacterial composition including a culture, lysate, extract, or filtrate thereof as an active ingredient.
|
|
WO/2023/227104A1 |
A co-culture system and method for synthesizing terpene. The system comprises at least one feeding strain of bacteria and at least one production strain of bacteria, wherein the feeding bacteria are used for providing mevalonic acid, and...
|
|
WO/2023/227820A1 |
The present invention relates to a method for producing improved strains of Saccharomyces cerevisiae with optimised wine-making properties, which comprises preparing at least one culture, wherein an initial strain of S. cerevisiae is in ...
|
|
WO/2023/226271A1 |
The present invention provides a biochar-based three-dimensional composite material and a method for remediating high-concentration chromium-contaminated soil. The biochar-based three-dimensional composite material is obtained by loading...
|
